Ashford Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-115,761
Closed -$8.35M 104
2022
Q1
$8.35M Sell
115,761
-1,393
-1% -$100K 0.9% 38
2021
Q4
$10.8M Sell
117,154
-7,800
-6% -$932K 1.07% 34
2021
Q3
$15.8M Sell
124,954
-2,674
-2% -$389K 1.44% 31
2021
Q2
$21.2M Buy
127,628
+789
+0.6% +$128K 1.91% 25
2021
Q1
$23.1M Buy
126,839
+5,272
+4% +$1.22M 2.15% 19
2020
Q4
$24.3M Buy
+121,567
New +$24.7M 2.35% 16

Other funds holding TDOC

Ashford Capital Management's TDOC Position: Q2 2022 in Review

Ashford Capital Management sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 115,761 shares — an estimated $8.35M sold.

Ashford Capital Management first reported a position in TDOC in Q4 2020 and held it in 6 quarters. The position peaked at $24.3M in Q4 2020. 550 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Ashford Capital Management reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Ashford Capital Management sold 115,761 Teladoc Health shares in Q2 2022, an estimated $8.35M.
  • Ashford Capital Management first reported a position in Teladoc Health in Q4 2020 and held it in 6 quarters.
  • Ashford Capital Management's Teladoc Health position peaked at $24.3M in Q4 2020.
  • 550 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Ashford Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.